A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis
Phase of Trial: Phase IV
Latest Information Update: 14 Dec 2018
At a glance
- Drugs Crisaborole (Primary)
- Indications Seborrhoeic dermatitis
- Focus Proof of concept; Therapeutic Use
- 04 Dec 2018 Status changed from not yet recruiting to recruiting.
- 18 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 25 Oct 2018.
- 02 Jul 2018 New trial record